Almirall stock holds firm after a Tradegate update
Published on 08/31/2026 at 19:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Almirall stock (ES0157097017) is trading at EUR 10.26 on Tradegate as of August 31, 2026, after a 0.58% daily move and a 20.25% drop this year. The latest company context includes half-year earnings for the period ended June 30, 2026 and an August 10 collaboration announcement that expanded its dermatology pipeline.
Half-year results matter
According to the Marketscreener company page, Almirall reported earnings results for the half year ended June 30, 2026. That reporting period is the key current fundamental anchor for the stock right now.
The same source also flags an August 10 collaboration with Shenzhen Crystalo Biopharma Technology Co., Ltd. for novel small molecules in medical dermatology, giving the share price a company-specific backdrop beyond the midyear update.
What the tape shows
The current move is restrained rather than dramatic, with the stock at EUR 10.26 and a 5-day change of -0.58% on August 31, 2026. The 1st Jan change of -20.25% shows that the shares are still trading well below where they started the year.
For investors, that combination of a fresh half-year reporting period and a negative year-to-date move keeps attention on execution in dermatology and on whether the collaboration can add more visible product momentum.
Dermatology is the core
Almirall, S.A. is a pharmaceuticals company whose business profile centers on dermatology, alongside other therapeutic areas and licensing activity. Its own-network model and R&D work are especially relevant when new development partnerships are announced.
That makes the August 10 collaboration relevant in practical terms: it fits the company's existing dermatology focus rather than stretching it into a new line of business.
Stock level to watch
The shares are sitting at EUR 10.26 as of August 31, 2026, with the year-to-date performance still negative at -20.25%. Tradegate quoted the stock at 09:29:19 BST, so the market is pricing the latest update against a weak 2026 backdrop.
More on Almirall
Company: Almirall, S.A.
ISIN: ES0157097017
Ticker: E2Z
Exchange: Tradegate
Price (as of August 31, 2026, 09:29:19 a.m. BST): EUR 10.26
Market cap: EUR 1.75 billion
Sector / Industry: Pharmaceuticals / Pharmaceuticals
Index membership: not stated in the available source material
Next earnings date: November 9, 2026
